Health-care-associated infection: Morbidity, mortality and costs

Hospital Medicine

Volumn 65, Issue 2, 2004, Pages 88-91

  Wilcox, Mark H ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; FLUCLOXACILLIN; METICILLIN; PENICILLIN G; VANCOMYCIN;

BACTERIAL INFECTION; BACTERIAL STRAIN; HEALTH CARE; HEALTH CARE COST; HEALTH CARE SYSTEM; HOSPITAL INFECTION; HUMAN; INFECTION PREVENTION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORBIDITY; MORTALITY; REVIEW; SEVERE ACUTE RESPIRATORY SYNDROME; COST; CROSS INFECTION; ECONOMICS; PENICILLIN RESISTANCE;

COSTS AND COST ANALYSIS; CROSS INFECTION; HEALTH EXPENDITURES; HUMANS; METHICILLIN RESISTANCE; MORBIDITY;

EID: 1642445554     PISSN: 14623935     EISSN: None     Source Type: Journal    
DOI: 10.12968/hosp.2004.65.2.12066     Document Type: Review

References (26)

1. Coello R, Glenister H, Fereres J et al (1993) The cost of infection in surgical patients: a case control study. J Hosp Infect 25: 239-50
2. Commission for Health Improvement (2003) Final Performance Indicators for Acute & Specialist Trusts. Available at: http://www.chi.nhs.uk/eng/ratings/ 2003/acute_list.shtml. accessed 13 October 2003
3. Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y (2003) Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 36: 53-9
4. Daum RS, Ito T, Hiramatsu K et al (2002) A novel methicillin-resistance cassette in community-acquired methicillin-resistant Staphylococcus aureus isolates of diverse genetic backgrounds. J Infect Dis 186: 1344-7
5. Department of Health and Social Security (DHSS) (1988) Hospital Infection Control. Guidance on the control of infection in hospitals. Joint DHSS/Public Health Laboratory Health Service Hospital Infection Working Group, London
6. Girard R, Fabry J, Meynet R, Lambert DC, Sepetjan M (1983) Costs of nosocomial infection in a neonatal unit. J Infect Dis 4: 361-6
7. Girou E, Stephan F, Novara A, Safar M, Fagon JY (1998) Risk factors and outcome of nosocomial infections: results of a matched case-control study of ICU patients. Am J Respir Crit Care Med 157: 1151-8
8. Gonzalez C, Gonzalez C, Rubio M, Romero-Vivas J, Gonzalez M, Picazo JJ (1999) Bacteremic pneumonia due to Staphylococcus aureus: A comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms. Clin Infect Dis 29: 1171-7
9. Haley RW, Schaberg D, Crossley K, Von Allmen S, McGowan J (1981) Extra charges and prolongation of stay attributable to nosocomial infections: a prospective interhospital comparison. Am J Med 70: 51-8
10. Haley RW (1985) Managing Hospital Infection Control for Cost Effectiveness: a Strategy for Reducing Infectious Complications. American Hospital Publishing, Chicago
11. Hospital Infection Working Group of the Department of Health and Public Health Laboratory Service (1995) Hospital Infection Control Guidance on the Control of Infection in Hospitals. BAPS, Health Publications Unit, Heywood, Lanes
12. Kappstein I, Schulgen G, Fraedrich G, Schlosser V, Schumacher M, Daschner FD (1992) Added hospital stay due to wound infections following cardiac surgery. Thoracic Cardiovasc Surgeon 40: 148-51
13. Kirkland KB, Briggs JP, Trivette SL, Wilkinson WE, Sexton DJ (1999) The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs. Infect Control Hosp Epidemiol 20: 725-30
14. Laing RB (1999) Nosocomial infections in patients with HIV disease. J Hosp Infect 43: 179-85
15. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR (1999) Guideline for Prevention of Surgical Site Infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. Am J Infect Control 27: 97-132
16. Manuel RJ, Kibbler CC (1998) The epidemiology and prevention of invasive aspergillosis. J Hosp Infect 39: 95-109
17. Mugford M, Kingston J, Chalmers I (1989) Reducing the incidence of infection after Caesarian section: implications of prophylaxis with antibiotics for hospital resources. Br Med J 299: 1003-6
18. National Audit Office (2000) The Management and Control of Hospital Acquired Infection in Acute NHS Trusts in England. National Audit Office, London
19. NHS Executive (1999) Governance in the new NHS: Controls assurance statements 1999/2000: risk management and organizational controls. Health Service Circular 1999/123. Available at: http://www.info.doh.gov.uk/doh/rm5.nsf/ b7546ce4a0608579002565c4003bf709/490210a4e0509441002567eb005de039/$FILE/ Hsc23.pdf accessed 13 October 2003
20. NHS Litigation Authority (2002) Clinical negligence scheme for trusts. Clinical risk management standards. Available at: http://www.nhsla.com/../docs/ CNST%20-%20General%20Manual%20June%202002.pdf accessed 13 October 2003
21. Plowman RM, Graves N, Roberts JA (1997) Hospital acquired infection. Office of Health Economics. BSC Print, London
22. Plowman R, Graves N, Griffin M et al (2001) The rate and cost of hospital-acquired infections occurring in patients admitted to selected specialties of a district general hospital in England and the national burden imposed. J Hosp Infect 47: 198-209
23. Weigelt JA, Dryer D, Haley RW (1992) The necessity and efficiency of wound surveillance after discharge. Arch Surg 127: 77-81
24. Wilcox MH, Cunniffe JG, Trundle C, Redpath C (1996) Financial burden of hospital-acquired Clostridium difficile infection. J Hosp Infect 34: 23-30
25. World Health Organization (2003) Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003. http://www.who.int/csr/ sars/country/table2003_09_23/en/accessed 13 October 2003
26. Zoutman R, McDonald S, Vethanayagan D (1998) Total and attributable costs of surgical-wound infections at a Canadian tertiary-care center. Infect Control Hosp Epidemiol 19: 254-9